General Characteristics
| Age: | 56 years |
| Gender: | Male |
| Disease Origin: | Sacral |
| Disease Status: | Recurrent, Metastatic |
| Metastatic Site(s): | Soft tissue |
| Sample Origin: | Soft tissue |
| Prior Radiation: | Yes |
| Prior Systemic Therapy: | Yes |
| Source: | Silke Bruderlein, Peter Moller University of Ulm Adrienne Flanagan University College London |
Molecular Features
| Cell Morphology: | Physaliferous |
| TBXT Expression: | Positive; 4x that of U-CH2 |
| TBXT Localization: | Nuclear |
| CD24 Expression: | Positive; 7x that of U-CH2 |
| HLA Type: | |
| Sequence Data: | |
| SMARCB1 Status: | |
| Validation Results: | Validation Report |
Growth Conditions
| Growth Medium: | IMDM: RPMI-1640 (4:1) +10% FBS |
| Freeze Medium: | 70% complete growth medium supplemented with an additional 20% fetal bovine serum and 10% DMSO |
| Culture Conditions: | Temperature: 37°C Atmosphere: air, 95%; carbon dioxide (CO2), 5% |
| Subculturing Instructions: | Cell Culture Procedures |
Publications
Characterized By:
|